
Loading, please wait...

Loading, please wait...

The One Health framework is increasingly central to global medical efforts, particularly in the fields of microbial ecology and microbiome science. This integrated approach recognizes that the health of humans, animals, and the environment is deeply interconnected. In Africa, these scientific domains are vital for solving complex public health and agricultural problems. Recent discussions at the ISME-Africa Morocco 2025 meeting highlighted both the significant progress and the existing gaps in regional research. While initiatives like the African BioGenome Project show great promise, the current research landscape remains largely fragmented. Therefore, transitioning toward coordinated pan-African networks is essential for global health representation.
Establishing Africa-specific genome reference datasets is a top priority for researchers. This step will ensure that precision medicine and diagnostic tools work effectively for diverse populations. Furthermore, fostering equitable partnerships between African and international institutions is crucial for sustainable development. Experts recommend integrating microbiome science directly into national policy frameworks. By adopting FAIR open-science practices, scientists can share data more transparently. Consequently, these efforts will strengthen bioinformatics capacity and allow for high-impact insights. Ultimately, advancing these priorities will accelerate clinical outcomes, such as better antimicrobial resistance (AMR) surveillance.
Strengthening Africa-led research will drive solutions for antibiotic discovery and crop productivity. Africa's unique microbial diversity holds vast potential for sustainable agricultural systems. Moreover, improved microbiome data will assist in tackling infectious diseases like HIV and tuberculosis. Clinical practitioners will benefit from more accurate datasets that reflect regional microbial profiles. These advancements support the overarching goals of the One Health framework. By bridging the current research gap, the medical community can deliver more personalized and effective care globally.
The One Health framework recognizes the fundamental connections between humans, animals, and the environment. By monitoring microbial systems across these sectors, clinicians can better predict disease outbreaks and manage antimicrobial resistance patterns more effectively.
Most current datasets focus on industrialized populations, which limits their global applicability. Africa-specific genomes ensure that diagnostic tools and precision medicine interventions are effective for African populations and people of African ancestry worldwide.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Hijri M et al. Advancing microbial ecology, microbiomes, and One Health in Africa: From regional initiatives to pan-African flagship programs. ISME J. 2026 May 21. doi: undefined. PMID: 42166181.
World Health Organization. One Health. 2024. https://www.who.int/news-room/questions-and-answers/item/one-health.
National Institute for Health and Care Research. Tackling bacterial and fungal antimicrobial resistance in sub-Saharan Africa and South Asia. 2026. https://www.nihr.ac.uk/funding/tackling-bacterial-and-fungal-antimicrobial-resistance-sub-saharan-africa-and-south-asia/36045.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


African researchers advocate for pan-African microbiome flagship programs and a One Health approach to address public health and agricultural challenges....
5 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today